Abbot Laboratories has received an emergency use authorization (EUA) from the FDA for its molecular test for the identification of SARS-CoV-2, the virus that causes COVID-19. The company has set out in deploying around 150,000 laboratory tests immediately. Some tests have already been sent to hospitals and academic medical center labs in 18 states including the […]
To access this post, you must purchase South Suburban News Subscription.